Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns naming Michaela Reilly .
Filed returns
5
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Roche | Health | Reframing state expenditure on innovative pharmaceuticals as a macroeconomic investment within national health and enterprise policy. (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2026 | Roche | Health | Revisions to the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) legislative frameworks in the context of Ireland’s H2 2026 Presidency of the Council of the European Union. (Legislation) | 5 | On lobbying.ie |
| May–Aug 2025 | ALONE | Health | Invite to Impact Assessment launch (Public policy or programme) | 20 | On lobbying.ie |
| Jan–Apr 2025 | GSK | Health | Immunisation policy (Public policy or programme) | 23 | On lobbying.ie |
| Sep–Dec 2024 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Alexion -Rare disease policy and election manifesto development (Public policy or programme) | 1 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 5 | 100.0% |